Foshan Yingxuan Equity Investment Partnership Enterprise (Limited Partnership) cancelled the acquisition of 2.56% stake in Zhejiang Biosan Biochemical Technologies Co., Ltd. from Dian Diagnostics Group Co.,Ltd..
July 28, 2020
Share
Foshan Yingxuan Equity Investment Partnership Enterprise (Limited Partnership) signed a share transfer agreement to acquire 2.56% stake in Zhejiang Biosan Biochemical Technologies Co., Ltd. from Dian Diagnostics Group Co.,Ltd. (SZSE:300244) for CNY 80 million on July 29, 2019. Post completion, Dian Diagnostics Group and its subsidiary will hold a total of 20.2096% stake in Zhejiang Biosan Biochemical Technologies. Zhang Min, Luo Wenmin, Dian Diagnostics Group, Zhejiang Dian Shenhai Cold-Chain Logistics Co., Ltd. and others will hold 21.5416%, 21.5416%, 15.1697%, 5.0399% and 36.7072% stake in Zhejiang Biosan Biochemical Technologies respectively. As of December 31, 2018, Zhejiang Biosan Biochemical Technologies reported total assets of CNY 1.02 billion, total common equity of CNY 797.48 million, revenue of CNY 757.53 million, EBIT of 121.68 million and net income of CNY 98.89 million. The transaction was approved by the board of directors of Dian Diagnostics Group on its 3rd directorate’s 41st meeting held on July 29, 2019. The transaction does not need approval from Dian Diagnostics Group's shareholders.
Foshan Yingxuan Equity Investment Partnership Enterprise (Limited Partnership) cancelled the acquisition of 2.56% stake in Zhejiang Biosan Biochemical Technologies Co., Ltd. from Dian Diagnostics Group Co.,Ltd. (SZSE:300244) on July 29, 2020.
Dean Diagnostic Technology Group Co., Ltd. is a company providing integrated solutions for medical diagnosis. The Company's main business involves inspection services, product services, health management, judicial expertise, contract research organization (CRO), cold chain logistics and other fields. The Company's business is mainly oriented to medical and health institutions at all levels, such as various general and specialized hospitals, community health service centers, township (town) health centers, physical examination centers, disease prevention and control centers, etc. The Company's products include Atomic Bomb in the field of liquid phase mass spectrometry, Hydrogen Bomb in the field of nucleic acid mass spectrometry, and Man-Made Satellite in the field of pathological diagnosis products and molecular diagnosis products, and others.
DIAN DIAGNOSTICS GROUP CO.,LTD. 
